Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the 2019 issue of Paths of Progress.
To see the entire publication, please
download the PDF version. If you'd like to receive a print version of Paths of Progress in the mail, please
complete this form.
Stopping cancer's mechanism of cell division with new drugs known as CDK4/6 inhibitors.
Natural killer cells are the first wave of defenders against infection, and they may have a new role in treating cancer.
Uncovering new strategies for identifying signs of pre-cancer – and stopping it before it starts.
Chemical biologists create small molecules to boost discoveries and prototype novel therapies.
Posted on June 10, 2019
Disclosure of Advisory Roles and Certain Industry Support
See an overview of relevant board memberships, outside support, and significant advisory roles as reported by several physicians and researchers featured in the 2019 issue of Dana-Farber's Paths of Progress magazine.
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to firstname.lastname@example.org.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.